





The MBR technology allows the exact levels to be established directly und quantitative in the blood, which means that therapeutic decisions can be arrived at earlier optimized.
In addition, the bilispect® measuring device’s button sensor provides the option of tracking the bilirubin breakdown caused by blue light therapy in a continuous measurement, and hence allows exposure times to be optimally dosed.
A sensor head placed on the skin projects a white light into the underlying tissue via a waveguide. Some of the projected light is absorbed by the various components of tissue, while some of it is reflected.
Another waveguide transmits the light reflected as a result of the physical conditions back to the device.
A spectrometer breaks the light down into its separate wavelengths and an electronic evaluation unit connected to the system analyses it.
The resulting data is then processed using an algorithm developed by MBR and visualised on the display of the device in the form of quantitative values measured for the parameters described above. Individual measurements and continuous measurements can also be carried out online. The device is powered by batteries. A matching intelligent charger is included, so the batteries will not be overloaded. With fully charged batteries, the device can measure for at least five hours in continuous operation
MBR Optical Systems
GmbH & Co. KG
Hölker Feld 5
D-42279 Wuppertal
Tel. +49 (0)202 / 64 74 - 550
Fax +49 (0)202 / 64 74 - 560
mbr@mbr-os.com
www.mbr-optical-systems.com